A medication called VX-548, developed by Vertex Pharmaceuticals, proved superior to placebo in two small Phase II clinical trials for two types of post-surgical pain, according to a study published in The New England Journal of Medicine in early August.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,